Reappraisal of the management of Vogt–Koyanagi–Harada disease: sunset glow fundus is no more a fatality

PURPOSE: Vogt–Koyanagi–Harada (VKH) disease is a primary autoimmune stromal choroiditis. Aim of the study was to gather a body of evidence from the literature and from experts that systemic corticosteroid combined with non-steroidal immunosuppressive therapy should become the standard of care in ini...

Descripción completa

Detalles Bibliográficos
Autores principales: Herbort Jr, Carl P., Abu El Asrar, Ahmed M., Yamamoto, Joyce H., Pavésio, Carlos E., Gupta, Vishali, Khairallah, Moncef, Tugal-Tutkun, Ilknur, Soheilian, Masoud, Takeuchi, Masuru, Papadia, Marina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5660833/
https://www.ncbi.nlm.nih.gov/pubmed/27844182
http://dx.doi.org/10.1007/s10792-016-0395-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5660833/
https://www.ncbi.nlm.nih.gov/pubmed/27844182
http://dx.doi.org/10.1007/s10792-016-0395-0

Ejemplares similares